VitaSpring Biomedical Co. Ltd. VSBC
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 161.80K | 75.80K | 78.40K | 133.20K | 99.10K |
| Depreciation & Amortization | -- | -- | 2.50K | 2.50K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 161.80K | 75.80K | 80.90K | 135.70K | 99.10K |
| Operating Income | -161.80K | -75.80K | -80.90K | -135.70K | -99.10K |
| Income Before Tax | -155.80K | -75.80K | -81.50K | -135.70K | -99.10K |
| Income Tax Expenses | -- | -- | 0.00 | 6.80K | 11.80K |
| Earnings from Continuing Operations | -155.80K | -75.80K | -81.50K | -142.50K | -110.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -155.80K | -75.80K | -81.50K | -142.50K | -110.80K |
| EBIT | -161.80K | -75.80K | -80.90K | -135.70K | -99.10K |
| EBITDA | -160.20K | -73.40K | -78.40K | -133.20K | -96.60K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 207.03M | 207.03M | 207.03M | 207.03M | 207.03M |
| Average Diluted Shares Outstanding | 207.03M | 207.03M | 207.03M | 207.03M | 207.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |